|
|
| OFFICE
FOR RESEARCH AFFAIRS |
NEXT
ISSUE OF ORA NEWS ONLINE
ORA News Online is currently operating on a "holiday
schedule". The last issue was released on 11/15/02
and the next issue will be Friday, January 10, 2003. New
Funding Opportunities will continue to be posted on the
ORA site daily. If you have any questions about policy changes
or funding opportunities, please do not hesitate to contact
us at 392-5398. (Posted 12/27/02)
NEW/
REVISED FORMS
Due to policy changes across the University, in Sponsored
Research and in the Office for Research Affairs, several
of our Administrative forms have been revised.
(1)
Sponsored Projects Approval Form-DSR-1 (Rev. 11/02)
A
new UFID number will be used in place of your Social Security
number in virtually all transactions you make with the university.
The DSR-1 form was recently revised to include UFID#
. As
of January 21, 2003 COM will only except
the 11/02 version of the DSR-1. Please update your files.
(2) Facilities
& Administrative (F&A)/ Indirect Cost (IDC) Return
Distribution (Revised 12/02)
The
Return Distribution of Indirect Cost, now termed Facilities
& Administrative Cost is required for all COM proposals
with overhead. The old form has been revised to include
the UFID# and to reflect a more accurate picture of the
distribution.
Note: All Clinical Trials must identify
the UF Center for Clinical Trials Research in the Center
split, and all proposal with Indirect costs (facilities
& Administrative Costs) from the College of Medicine
must identify a Board of Regents-approved Center to receive
the extra 7.5% indirect cost return.
As of January 6, 2003 this form must be
turned in along with the DSR-1 when a proposal is submitted
for signatures.
(3)
UF/COM
PHS 398 Face Page Sample
The COM's sample NIH Form Page 1 (Face Page) has been
revised to include the following:
-Institutional
Profile Number: 513806
-Congressional District: 6
-E-mail of Official Signing for Organization : proposals@rgp.ufl.edu
(Posted 12/27/02)
| DIVISION
OF SPONSORED RESEARCH |
NEXT
ISSUE OF FYI DIGEST
Please note that the next issue of FYI will be Friday, January
3, 2003. (Posted 12/27/02)
TRANSFER
OF UFF DONOR FUNDS TO UF THROUGH DSR
In order for DSR to establish the initial UF companion account
for purposes of receiving disbursements from University
of Florida Foundation (UFF) donor funds, the following will
need to be provided:
continued
on Right..........................................
|
|
.................continued
(1) A completed DSR-1
Please make sure you include the UFF Fund # & Title
(2) UFF Disbursement Request Form (UFF-D)
Please make sure you include UFF Fund Number,a
clear statement describing the purpose and use of funds,
and Fund Administrator information.
(3) Transfer to UF Request Form (UFF-U)
Please make sure you include UFF Fund Number and Title,
Project Period (if indefinite, state indefinite), a
clear statement describing the purpose and use of funds,
a clear statement indicating donor restrictions, (if
none, state none), a clear statement indicating reporting
requirements (if none, state none), and Fund Administrator
information.
Please complete all items listed above before submitting to
ORA for College of Medicine review and approval. Incomplete
items will be returned. The
following UFF Business Forms can at https://intranet.uff.ufl.edu/BusinessForms.asp
(1) UFF
Disbursement Request (UFF-D)
(2) UFF
Transfer to UF (UFF-U)
For
the full version of this annoucement, go to
Transfer of UFF Donor Funds to UF of the December
13, 2002 issue of the FYI
Digest (Posted 12/27/02)
NEW
PROPOSALS MUST INCLUDE INSURANCE BENEFITS FOR POSTDOCS
Abstract Postdoctoral Associates play a vital role in the
research mission of the university. In order to give postdocs
the benefit of health care for themselves and their families,
the following policy has been adopted by the UF Board of
Trustees: Effective January 7, 2003, or shortly thereafter,
the title Postdoctoral Associate at the University of Florida
will change from a student title to a faculty title. This
rule change has consequences for both the Postdoctoral Associates
themselves and for the grants on which they are supported.
(Note: Postdoctoral Fellows who receive independent fellowship
awards are not included in this rule.)
Benefits. With this rule change, Postdoctoral
Associates will become entitled to state health benefits,
just as other faculty are now. Grants will be charged for
the state contribution portion of the benefit, which, effective
January 1, 2003, amounts to: $2,986.32 per year
($248.86 monthly) for an individual and $6,106.56 ($508.88
monthly) for a family. These amounts are subject
to change each fiscal year.
Grant
Budgets. Consequently, Principal Investigators
whose grants will support Postdoctoral Associates should
budget this cost in addition to the 8.3% fringe benefits
rate for Postdoctoral Associates. Effective immediately,
this is required for all new grant submissions to external
agencies. No funds for retirement benefits need
to be added to budgets, since Postdoctoral Associates will
not be eligible for state retirement benefits. Questions
about proposal budgets may be directed to the Division of
Sponsored Research, Proposal Processing Office, 392-9267
or ufproposals@rgp.ufl.edu.
Spring
semester transition. Postdoctoral Associates will
become entitled to the state health benefit as soon as the
new rule goes into effect, which is expected to be approximately
January 7, 2003. Because existing grants may not have funds
appropriately budgeted to handle this additional charge,
there is a mechanism in the Spring 2003 semester to deal
with this possibility. Principal Investigators may reappoint
Postdoctoral Associates as Adjunct Postdoctoral Associates.
During the Spring semester, Adjunct Postdoctoral Associates
will be paid from OPS funds and will not be entitled to
the state health benefit. Questions about reappointment
of Postdoctoral Associates for the Spring semester should
be directed to Ms. Janet Malphurs, Office of Academic Personnel,
392-1251. (Posted 12/27/02) |
|
|
|
IRB REVIEW OF GRANT APPLICATIONS
The
University of Florida IRBs are currently requesting that
copies of federal grant applications be submitted with IRB
protocols. The following questions and answers are provided
to explain this requirement.
1.
Why is the IRB requiring that a copy of the grant be submitted?
Department of Health and Human Services (DHHS) regulations
at 45 CFR 46.103(f) require that each application or proposal
for HHS-supported human subject research be reviewed and
approved by the Institutional Review Board. The University
of Florida is obliged, therefore, to review these proposals.
2.
What portion of the grant must be submitted?
Investigators must submit a copy of the entire proposal
(exclusive of apendices). If a grant is linked to multiple
IRB protocols then the IRB needs to know which protocols
so that they can all be reviewed. Only one copy of the grant
proposal is required in the IRB office. The IRB cannot review
a protocol unless the entire grant application has been
submitted.
3.
What exactly is the IRB looking for?
The grant proposal must be found to be consistent
with information related to the protection of human subjects.
Examples include information about (i) the number and qualifications
of collaborating investigators and other members of the
research team; (ii) cooperating institutions or performance
sites that may require separate or additional IRB review
or an Assurance of Compliance; (iii) characteristics of
proposed research facilities that may affect subject safety
or the confidentiality of data; (iv) the feasibility of
financial commitments made to subjects; and (v) the cost
of proposed subject protection measures, such as consent
monitors or translators.
4.
What will happen if the research protocol is found to be
inconsistent with the proposal?
The
IRB protocol must be consistent with the grant proposal.
Any discrepancies will require the PI to either amend the
current protocol or to submit a new protocol that is consistent
with the grant application. If the IRB and PI are unable
to reconcile these differences then the Division of Sponsored
Research will freeze any funds in the account until the
IRB determines that the application and protocol are consistent.
(Posted 12/27/02)
HEALTH
CENTER IRB EXPLICIT CHANGES AND TABLED NOTICES
Two
new IRB-01 forms are now available to organize the flow
of paperwork in the IRB Office.
·
The all-new Explicit
Change Response form can be used when you submit “explicit
changes” based on IRB recommendations.
· The all-new Tabled
Submission Response form
can
be used to communicate a reply to the IRB regarding an IRB-issued
“tabled” notice.
Use
of these forms is not required at this time. As usual, all
investigators are strongly encouraged to visit the IRB website
regularly to review updated IRB information. All submissions
to the IRB should be made using current
IRB forms which are also located at the IRB website.
For more information regarding Human Subjects approval
or requirements in Health related sponored research, go
to Health Center Institutional
Review Board. (Posted
12/27/02)
MANDATORY
HIPAA TRAINING PROGRAMS
On April 14, 2003, all human research conducted at or by
the University of Florida, Shands Hospitals, the Malcom
Randall VA Hospital, and all other similar organizations
throughout the country must be in compliance with the new
Health Insurance Portability and Accountability Act (HIPAA)
Privacy regulations.
continued
on Right.............................................. |
|
.................continued
To ensure that UF’s researchers are able to carry
on their research without incurring legal liability for
themselves and for UF, all principal investigators will
be required to attend a one-hour HIPAA research training
session before April 14, 2003. The times and dates for these
training sessions are available at the following link: http://irb.ufl.edu/irb01/HIPAA.htm.
Further, in preparation for HIPAA:
· Please review your current active protocols and
close (by
submitting appropriate documentation for closure to the
IRB) any of those protocols that are not currently active.
This will save you and the IRB additional work.
· Current active protocols on which you will continue
to enter
subjects after April 14, 2003 will require you to submit
a revised informed consent or an addendum to the consent;
templates for both will be provided by the IRB. These revisions
must be approved by the IRB before that date (thus you must
submit before April 14, 2003). HIPAA may also require other
changes, in particular, how you recruit subjects. Those
changes must be submitted and approved by the IRB. (Note:
subjects that have consented prior to April 14, 2003, will
not need to be re-consented).
· In order to avoid personal legal liability you
will need to make
the HIPAA-required changes to your active protocols before
April 14, 2003. If these changes are not made to your protocols
they will be closed to further subject accrual until such
changes are reviewed and approved by the IRB.
This process will require a time investment by each investigator,
and a significant time investment by the IRB and the IRB
Office Staff. Please go early to the mandatory HIPAA training
session to give yourself time to make these changes and
avoid any interruption in your research.
For more information on the Madatory HIPAA Training
Programs contact IRB-01 at 846-1494 or e-mail at irb1@grove.ufl.edu.
(Posted 12/27/02)
Pilot
and Feasibility Studies of Molecular Therapies
for Cystic Fibrosis and other Genetic Diseases
Background:
Seed funding will be provided by the joint University of
Florida/Johns Hopkins Molecular Therapy Core Center for
up to 2 pilot and feasibility studies pertinent to the development
of new cellular and/or molecular therapies for genetic diseases,
including cystic fibrosis.
Funding:
$50,000 per year for two years. The second year funding
will be contingent on awarding of the NIH grant and upon
receipt of a progress report.
Eligibility:
Faculty appointment at the University of
Florida or Johns Hopkins University.
Submission Date: December 31, 2002
Funding Date: February 1, 2003
Proposal
Format: A four-page (maximum) research plan summary
is requested, to include Specific Aims, Background and Significance,
Preliminary Data (if vailable), and Research Design and
Methods. An NIH-style biosketch and a statement of Other
Support are also required. Budgets will be requested after
award decisions are made.
Submission
logistics:
Options include
*
Email of the documents to Cathy Hoover at choover@gtc.ufl.edu
* Delivery to Dr. Terry Flotte, ARB Room R1-118 UF: Attn.
Cathy Hoover
* Fedex to Dr. Terry Flotte, University of Florida
Pediatrics ARB Room R1-118, 1600 SW Archer Rd., Gainesville,
FL 32610-0296
* Fax to Cathy Hoover 392-0481 (Posted
12/27/02) |
|
|
| AMERICAN
CANCER SOCIETY-FL |
Important
Notice:
From:
Fl-Division of the American Cancer Society
To: Whom It May Concern in the College
of Med.
This notice is to inform those who were planning to submit
a grant application for the Jan. 15, 2003, deadline that
the Florida Division Research Program will not be
entertaining a second cycle of research-grant applications
this year, due to limited availability of funds. This
does not affect grant applications that are being submitted
to the National Research Program.
If you have questions, please call:
Nina
Entrekin, RN, MN
Florida Division of American Cancer Society
1-800-444-1410, ext. 408
| NATIONAL
INSTITUTES OF HEALTH |
NIH
EXTRAMURAL LOAN REPAYMENT PROGRAM REGARDING CLINICAL AND
CLINICAL RESEARCHERS
The National Institutes of Health (NIH) announces
the extension of the deadline for the 2003 Extramural Loan
Repayment Program for Clinical Researchers (LRP-CR) and
2003 Extramural Loan Repayment Program for Program for Pediatric
Researchers (PR-LRP). The program provides for the repayment
of up to $35,000 of the principal and interest of the educational
loans.
continued
on Right.......................................... |
|
.................continued
This year's program is not limited to NIH grantees as was
the fiscal year 2002 requirement. The new deadline is now
January 31, 2003.
For
the full versions of these annoucements, go to NOTICE:
NOT-OD-03-012 and NOTICE:
NOT-OD-03-013 of the December
06, 2002 issue of the NIH
Guide
(Posted 12/27/02)
NIDDK
ANNOUNCES AVAILABILITY OF SPECIAL FUNDS FOR SELECTED PRGM.
ANNOUNCEMENTS
The
National Institute of Diabetes and Digestive and Kidney
Diseases (NIDDK) announces a subset of
active program announcements (PAs) that are of sufficiently
high priority to warrant a set-aside of NIDDK "Special
Emphasis" funds. Special funds have been set aside
to support applications that are responsive to these PAs,
but have received scores beyond the general payline.
These
funds are separate from those for Requests for Applications
and other initiatives. In addition to the criterion for
responsiveness, applications must be of sufficiently high
merit and program relevance to warrant funding beyond the
announced payline.
Specific PAs on the Special Emphasis list will change over
time, along with the NIDDK's funding priorities. Therefore,
it is important that you refer to the following web site
for the most current list of the PAs in this special category:
http://www.niddk.nih.gov/fund/crfo/specialpas.htm
The list of all active NIDDK PAs is located at:
http://www.niddk.nih.gov/fund/crfo/pas.htm.
For
the full version of this annoucement, go to NOTICE:
NOT-DK-03-001 of the November
29, 2002 issue of the NIH
Guide. (Posted 12/27/02) |
NEW FUNDING
OPPORTUNITIES
|
|
Pfizer
is accepting proposals 2003
Postdoctoral Fellowshp Grants in Rheumatology/Immunology.
Applications are due to ORA for an
internal competition by January 3, 2003..
Only one application from each institution
will be accepted. (Posted
12/27/02)
Pfizer
is accepting proposals 2003
Postdoctoral Fellowshp Grants in Cardiovascular Medicine.
Applications are due to ORA for an
internal competition by January 3, 2003..
Only one application from each institution
will be accepted. (Posted
12/27/02)
Pfizer
is accepting proposals 2003
Visiting Professorship Program in Rheumatology.
Applications are due to ORA for an internal competition
by January 10, 2003. Only
one application from each institution will be accepted.
(Posted 12/27/02)
Pfizer
Pharmaceuticals Group is accepting
proposals 2003
Vigara Research Grants Program.
Applications are due to ORA for an internal competition
by January 15, 2003. Applications
are available on line by Clicking
here
(Posted 12/27/02)
AMA
Foundation is accepting applications for the
2002
Health Literacy Grants to Medical Students. Applications
are due to the foundation by January 15, 2003.
The
Robert J. & Clarie Pasarow Foundation is
accepting applications for the
Robert J. & Clarie Pasarow Medical Research Awards.
Nominations should be received by January 20, 2003.
For information on application procedures, Contact Dr.
Kirsten Madsen in the Office for Research Affairs.
Pfizer
is accepting proposals 2003
Postdoctoral Fellowship Grants in Infectious Diseases.
Applications are due to ORA for an
internal competition by January 21, 2003.
Only one application from each institution
will be accepted. (Posted
12/27/02)
American
Federation for Aging Research (AFAR) is
accepting proposals for the 2003
Merck/AFAR Research Scholarships in Geriatric Pharmacology
for Medical and Pharmacy Students.
Applications are due to AFAR by January 22, 2003.
Download 2003 application.
American
Federation for Aging Research (AFAR) is
accepting proposals for the 2003
Merck/AFAR Research Scholarships in Geriatric Pharmacology
for Medical and Pharmacy Students.
Applications are due to AFAR by January 22, 2003.
Download 2003 application.
The California
Table Grape Commission is requesting applications
for the 2003-2004
Annual Research Grant program. The deadline for applications
is January 24, 2003.
The California
Table Grape Commission is requesting applications
for the 2003-2004
Annual Research Grant program. The deadline for applications
is January 24, 2003.
The
Rett Syndrome Research
Foundation is accepting applications for Research
Grants and Postdoctoral Fellowships. A Letter of Intent
is due to the foundation by January 31, 2003
continued
on Right.............................................. |
|
.................continued
The
Florida Space Grant Consortium (FSGC) is accepting
applications for the 2003
Florida Space Research & Education Grant program,
Space
Grant Fellowship program, and the Undergraduate
Space Research Participation program. Letters of Intent
for all 3 programs are due by January 31, 2003.
The
Ellison Medical Foundation is accepting applications
for the Ellison
Medical Foundation New Scholars Program in Global Infectious
Disease for 2003. Applications
are due to ORA for an internal competition by January
31, 2003. Only one
application from each institution will be accepted.
The
Damon Runyon Cancer Research Foundation is
accepting applications for the Damon
Runyon~Lilly Clinical Investigator Award. Applications
are due to ORA for an internal competition by February
1, 2003. Only two
applications from each institution will be accepted.
Mary
Kay Ash Charitable Foundation is accepting
applications for their Innovative/Translational
Cancer Research program. Applications
are due to ORA for an internal competition by February
14, 2003. Only one
application from each institution will be accepted.
American
Federation for Aging Research (AFAR) is
accepting proposals for the 2003
Glenn/AFAR Scholarships for Research in the Biology of Aging.
Applications are due to AFAR by February 26, 2003.
Download 2003 application.
The
American Geriatrics Society is accepting applications
for the
2003 Geriatrics Education for Specialty Residents (GESR)
program. Applications are due
to ORA for an internal competition by February 28,
2003. Only one application
from each department will be accepted.
The
Ellison Medical Foundation is accepting applications
for the Ellison
Medical Foundation Senior Scholar Award in Global Infectious
Disease for 2003. A Letter of
Intent is due to the foundation by February 28,
2003.
The
Damon Runyon Cancer Research Foundation is
accepting applications for the Damon
Runyon Fellowship Award. Applications
are due to foundation by by March 15, 2003.
Ochsner
Clinic Foundation is accepting nominations
for the 2003 Alton Ochsner Awards
Relating Smoking and Health.
Nominations are due to the foundation by by March
31 , 2003.
Bristol-Myers
Squibb Company is accepting applicaitons for
the for Distinguished
Achievement in Infectious Diseases Research Award. Nominations
are due to Bristol-Myers by April 7, 2003.
Download
2003 Nomination form.
Health
Effects Institute is accepting applications
for the Walter
A. Rosenblith New Investigator Award. Applications are
due to the Institute by April 14, 2003.
National
Kidney Foundation of Florida is accepting
applications for their 2003
fellowship program. Applications are due to the foundation
by April 30, 2003.
For
funding opportunities annouced by Research and Graduate
Programs FYI http://rgp.ufl.edu/fyi/
New NIH notices, requests for applications and program announcements
can be found at
NIH Notice |
|
INTERNAL
DEADLINES
|
|
Certain
agencies announce Requests for Applications that limit the
number of proposals that can be submitted by the University.
In these instances, the Office for Research Affairs will
post an internal deadline for interested faculty to submit
a Letter of Intent to the Office for Research Affairs.
If
there are more applicants interested in submitting a proposal
than the agency's guidelines allow for, an internal review
process will be coordinated by ORA. ORA will only coordinate
the requests that are specifically for health related projects.
RGP will coordinate all other requests. There is not always
a candidate who applies for an award. If you are interested
in a funding opportunity and the internal deadline has passed,
check with ORA to see if this opportunity is still available.
Contact Dr. Madsen
with questions related to funding opporunities or internal
competitions.(Posted 12/27/02)
|
|
Upcoming
Internal Deadline
Pfizer
is accepting proposals 2003
Postdoctoral Fellowshp Grants in Rheumatology/Immunology.
Applications are due to ORA for an
internal competition by January 3, 2003.
Only
one application from each institution will be accepted.
(Posted
12/27/02)
Pfizer
is accepting proposals 2003
Postdoctoral Fellowship Grants in Cardiovascular Medicine.
Applications are due to ORA for an
internal competition by January 3, 2003.
Only
one application from each institution will be accepted.
(Posted
12/27/02)
Pfizer
is accepting proposals 2003
Visiting Professorship Program in Rheumatology
Applications
are due to ORA for an internal competition by January
10, 2003.
Only
one application from each institution will be accepted
|
|
CONFERENCES
| | |